Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01927770 · ClinicalTrials.gov registry record

A Study of Consent Forms for Whole Exome and Whole Genome Sequencing

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
212
Enrollment target

NCT01927770 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 212 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01927770 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
212 participants
Enrollment target

Study Summary

Background: The purpose of this study is to investigate the process of consenting participants to whole exome/genome sequencing and its outcomes. It is unknown how best to consent people to this new technology. NO GENOME SEQUENCING IS OFFERED AS PART OF THIS STUDY. This protocol is a companion to other NIH studies that involve genomic sequencing. Participants must be enrolled in a parent NIH study that is collaborating on this consent study to be eligible. Currently this involves only one NIH study. Objectives: \- To learn the best way to help participants understand sequencing, so they can decide whether to join studies that use it. Eligibility: * Adults at least 18 years old who are enrolled in a National Institutes of Health (NIH) study that uses WES/WGS. * Adults at least 18 years old whose children are enrolled in an NIH study that uses WES/WGS. Design: * Participants will take part in the study either in person or over the phone. * Participants will review two sequencing consent forms with a genetic counselor. * Before and after meeting with the counselor, participants will answer several questions about sequencing. Each questionnaire will take about 15 minutes. * Six weeks later, participants will answer questions about sequencing. This will take about 15 minutes.

Trial Details

FieldValue
Enrollment Target 212 participants
Start Date 2013-12-16
Est. Completion 2021-11-08

What the Registry Record Tells You About NCT01927770

The ClinicalTrials.gov registry entry for NCT01927770 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01927770 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01927770 about?

NCT01927770 is a clinical study titled "A Study of Consent Forms for Whole Exome and Whole Genome Sequencing". Background: The purpose of this study is to investigate the process of consenting participants to whole exome/genome sequencing and its outcomes. It is unknown how best to consent people to this new technology. NO GENOME SEQUENCING IS OFFERED AS PART OF THIS STUDY. This protocol is a companion to o...

What is the current status of trial NCT01927770?

This trial is currently completed. The enrollment target is 212 participants. The study started on 2013-12-16. Estimated completion is 2021-11-08.

Who is sponsoring clinical trial NCT01927770?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.